SOHM, Inc. SHMN
Set alert
0.00 USD 0.00 +16.67%
As of Nov 2, 11:17 AM ET
0.0007 Day range 0.0007
0.0006 52-week range 0.0015
- YTD
- -22.22%
- 1 year
- -45.31%
- Open
- 0.0007
- Prev close
- 0.0006
- Mkt cap
- 2.03M
- Vol
- 1.18M
- Avg vol
- 910.45K
- EPS
- -0.002
- P/E
- 0.00
More statistics
- Low
- 0.0007
- High
- 0.0007
3M chart
Signals (28)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
Financials — quick view
SHMN Revenue — quarterly 231.86K
SHMN Net income — quarterly -249.58K
SHMN EPS — quarterly 0.00
News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
- SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
- SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities
- SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
- SOHM, Inc. Appoints Ravi Kapoor as an Independent Director
- SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
- SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
- SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development
- SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
Your note
Sign in to keep a note on SHMN — it syncs with the Stock Master app.